Potassium Chloride Tablet, Extended Release
Product Images NDC 42291-507

2 FDA label images from Avkare · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 42291-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

507 01 20meq

507 01 20meq
Potassium Chloride Extended-Release Tablets, USP 20 mEq K in a package of 100 tablets by AvKARE. The label indicates the product uses micro-dispersible technology and is for oral use. The AvKARE logo and NDC 42291-507-01 are also visible.*
FDA Label Image

507 50 20meq

507 50 20meq
Potassium Chloride Extended-Release Tablets, USP 1500 mg oral tablets by AvKARE. The label shows the product name, strength, micro-dispersible technology, quantity of 500 tablets, NDC 42291-507-50, and prescription-only status. Additional storage and handling information is included along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.